Skip to content

Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy

Randomized Controlled Study: Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy Relating to Early Mobilization and Analgesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02125903
Enrollment
44
Registered
2014-04-29
Start date
2013-05-31
Completion date
2014-11-30
Last updated
2015-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adductor Canal Block, Femoral Nerve Block, Total Knee Arthroplasty, Total Knee Replacement

Brief summary

The blockade of the femoral nerve (FNB) is the most common postoperative pain therapy after total knee replacement. Because of motor-driven weakness of the quadriceps muscle induced by femoral nerve block mobilization of Patients is difficult even dangerous (falls) and hospital stays are extended. An alternative method could be an adductor canal block (ACB). Anatomical studies of the adductor canal demonstrated that the adductor canal contains the saphenous nerve, a pure sensory nerve for medial and anterior aspects of the knee and the tibia without any motor function. This prospective, double-blinded, randomized study investigates the effect of FNB and ACB on quadriceps motor weakness and analgesia determined by Numeric Rating Scale (NRS). We expect the ACB to be superior in muscle strength but equal in pain score. Both groups receive an additional anterior sciatic nerve block for complete sensory block of the operated knee

Interventions

DRUGRopivacaine

Regional Anesthesia performed with 0.375% Ropivacaine 15ml (56,25mg)

Sponsors

Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with knee replacement therapy and general anaesthesia * informed consent * preoperative timed up and go test performable

Exclusion criteria

* emergency patients * BMI \> 40 kg/m2 * American Society of Anaesthesiologists physical status (ASA) 4-5 * severe chronic obstructive pulmonary disease (COPD) * rheumatic arthritis, diabetic Polyneuropathy, M. Parkinson * nerve injury of lumbosacral plexus * coagulopathy with bleeding tendency * not capable of speaking or understanding german or english

Design outcomes

Primary

MeasureTime frameDescription
Timed-Up and Go-test for mobility evaluationthird postoperative dayThe patient is observed and timed while he rises from an arm chair, walks 3 meters, turns, walks back, and sits down again.

Secondary

MeasureTime frameDescription
CAS (Cumulated Ambulation Score)24,48,72 hours postoperativeCumulated Ambulation Score is calculated with routine data. Measurement for ambulation ability
Pain Scores6, 24, 48, 72 hours postoperativeNumeric Rating Scale (NRS), 0-10 for Rest / Stress. in Addition total Body NRS Pain
Ropivacaine consumption (each catheter)24, 48, 72 hours postoperativeMeasurement of the total amount
Mobility Score (MoSc)24,48,72 hours postoperativeIs calculated with routine data. Measurement for overall mobilization (none- passive mobilization, sitting, standing, walking with walking device, walkin free or with crutches)
Analgesic regimenpreop and 0, 6 , 24, 48, 48 hours postoperativeDocumentation of analgesic prescriptions and rescue medications during postoperative course
Quadriceps strength6, 24, 28, 72 hours postoperativeNumeric Scale (0-5)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026